TIGITRAX 120mg gastro-resistant capsules medication leaflet

L04AX07 dimethyl fumarate • Antineoplastic and immunomodulating agents | Immunosuppressants | Other immunosuppressants

Dimethyl fumarate is a medication used for the treatment of relapsing-remitting multiple sclerosis. It works by reducing inflammation and protecting nerve cells from oxidative stress.

The medication is taken orally, usually twice daily, as directed by a doctor. It is important to follow the recommended dose to minimize the risk of adverse effects.

Side effects may include flushing, nausea, diarrhea, abdominal pain, or a decrease in lymphocyte count. In rare cases, severe allergic reactions or progressive multifocal leukoencephalopathy may occur.

Dimethyl fumarate is not recommended for patients with hypersensitivity to this medication or active severe infections.

General data about TIGITRAX 120mg

Substance: dimethyl fumarate

Date of last drug list: 01-03-2025

Commercial code: W70879003

Concentration: 120mg

Pharmaceutical form: gastro-resistant capsules

Quantity: 100

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PHARMADOX HEALTHCARE LTD. - MALTA

Holder: ADALVO LIMITED - MALTA

Number: 15789/2025/03

Shelf life: 3 years

Pharmaceutical forms available for dimethyl fumarate

Concentrations available for dimethyl fumarate

120mg, 240mg, 30mg